}
  • Home   ›
  •   Indian Tenders   › Tender Notice : 48391788

    • Tender for Dulaglutide 1.5 Mg/0.5 Ml+Human Insulin Analogue+30% Soluble Insulin +Insulin Aspart, samastipur-Bihar

    East Central Railway has published Tender for Dulaglutide 1.5 Mg/0.5 Ml+Human Insulin Analogue+30% Soluble Insulin +Insulin Aspart. Submission Date for this Tender is 28-03-2025. Medicine Tenders in samastipur Bihar. Bidders can get complete Tender details and download the document.




    Tender Notice

    48391788
    Tender for Dulaglutide 1.5 Mg/0.5 Ml+Human Insulin Analogue+30% Soluble Insulin +Insulin Aspart
    Tender
    Indian
    Bihar
    Samastipur
    28-03-2025

    Tender Details

    Supply Of Dulaglutide 1.5 Mg/0.5 Ml+Human Insulin Analogue+30% Soluble Insulin +Insulin Aspartdulaglutide 1.5 Mg/0.5 Ml+Human Insulin Analogue+30% Soluble Insulin +Insulin Aspart,(Ph No.:10046) Human Insulin Analogue Inj (Biosynthetic R-Dna Origin) Soluble Insulin Aspart 100 Iu/Ml In 3.0 Ml Precision Delivery Device- Novorapid /Flexpens ] , (Ph No.:10059) 30% Soluble Insulin Aspart + 70% Insulin Aspart Protamine - 10 0 Iu X 1 Ml X 3 Ml - Novomix Penfills ] , [Ph.No.10129] Dulaglutide 1.5 Mg/0.5 Ml Pfs Inj. ] , [Ph No. 10134] Insulin Aspart (R-Dna Origin) + Degludec Solution 30-70; 100 Iu/ Ml Flexitouch Pen. ] => Limited

    Key Value

    Document Fees
    Refer document
    EMD
    Refer document
    Tender Value
    Refer document
    Disclaimer :
    We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
    Tell us about your Product / Services,
    We will Find Tenders for you
    Cnet Technologies

    We are a group of professionals specializing in custom software development, web development, mobile app development, IOT base solutions, web design, graphics & Enterprise solutions provid.

    About Us

    Services

    Browse Tenders

    For Sales Inquiry

    Connect With Us

    Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

    For Tender Information Services Visit : TenderDetail